品牌现货直购
供应商:我要出现这里



查看所有供应商和价格请点击:

169332-60-9生产厂家

169332-60-9价格

169332-60-9

169332-60-9结构式
169332-60-9结构式
  • 常用中文名:Ac-DEVD-CHO
  • 常用英文名:Ac-DEVD-CHO
  • CAS号:169332-60-9
  • 分子式:C20H30N4O11
  • 分子量:502.47200
  • 相关类别: 生物化工 多肽
  • 发布时间:2019-01-29 16:42:22
  • 更新时间:2024-01-05 19:19:00
  • Ac-DEVD-CHO 是一种特异性 Caspase-3 抑制剂,Ki 值为 230 pM.

化源商城直购

中文名 乙酰基-天冬氨酰-谷氨酰-缬氨酰-天冬氨醛
英文名 ac-devd-cho
英文别名 N-Acetyl-Asp-Glu-Val-Asp-al
描述 Ac-DEVD-CHO 是一种特异性 Caspase-3 抑制剂,Ki 值为 230 pM.
相关类别
靶点

Caspase 3:0.23 nM (Ki)

Caspase-8:0.92 nM (Ki)

Caspase-7:1.6 nM (Ki)

Caspase-10:12 nM (Ki)

Caspase-1:18 nM (Ki)

Caspase-6:31 nM (Ki)

Caspase-9:60 nM (Ki)

Caspase-4:132 nM (Ki)

Caspase-5:205 nM (Ki)

Caspase-2:1710 nM (Ki)

体外研究 为了确定胱天蛋白酶-3在SLNT诱导的细胞凋亡中的作用,使用半胱天冬酶-3抑制剂(Ac-DEVD-CHO)。添加Ac-DEVD-CHO可显着预防SLNT诱导的细胞凋亡(从32.91±1.21%降至15.88±1.58%,而NC和Ac-DEVD-CHO组分别为6.45±0.96%,7.77±0.79%)[2] ]。经金丝桃素介导的PDT处理后,经zVAD-fmk(5.32%)或Ac-DEVD-CHO(7.43%)预处理的细胞凋亡率明显下降[3]。值得注意的是,10μmol/ L Ac-DEVD-CHO部分阻断了SIN诱导的细胞凋亡的作用并减少了凋亡细胞核的数量。 SIN的这些作用被胱天蛋白酶-3抑制剂Ac-DEVD-CHO阻断。喜树碱(4μM)是一种阳性对照,可增加caspase-3活性,这也被Ac-DEVD-CHO阻断[4]。
体内研究 与模型组比较,CI组血清BUN浓度在术后各时间点均明显降低,6小时后Cr明显降低,12小时和24小时恢复为假手术组;在所有时间点,血清TNF-α,IL-6浓度均降低,IL-10浓度显着升高。 [TNF-α(μg/ L)6小时:436.2±64.2对比653.6±8.9,12小时:233.4±85.4对比579.7±137.1,24小时:151.0±90.3对比551.0±119.8,IL-6(μg)/L)6小时:1033.2±345.8对比1 595.3±159.4,12小时:366.3±68.3对比1 330.7±249.8,24小时:241.2±208.4对比815.3±572.7,IL-10(μg/ L)6小时:33.6±10.4对比26.6±4.5,12小时:37.2±5.0对比24.5±4.3,24小时:38.3±5.5对比18.2±1.6,所有P <0.05];肾细胞凋亡率在所有时间点均显着下降:凋亡率为6小时:(13.9±3.2)%对比(18.3±1.4)%,12小时:(10.5±3.6)%对比(15.9±3.5)% ,24小时:(8.4±1.8)%vs.(12.5±2.1)%[5]。
细胞实验 将OCL与RANKL一起温育,并用含有或不含特异性半胱天冬酶-3抑制剂Ac-DEVD-CHO(10μM)的0.5mM SIN处理24小时。在处理结束时,用PBS洗涤细胞,并用10μMHoechst33258染料染色15分钟。用荧光显微镜捕获staineing细胞的图像。通过计数每个孔中具有凋亡核浓缩的细胞数来评估差异[4]。
动物实验 对102只雄性小鼠进行盲肠结扎和穿刺或假手术。根据随机数表将动物分成三个相等的组(n = 34):假手术组,模型组和半胱天冬酶-3抑制剂(CI)组。在CLP前30分钟,在CI组中皮下注射Ac-DEVD-CHO(4μg/ g)。测定血尿素氮(BUN)和肌酐(Cr)水平,用酶联免疫吸附试验测定肿瘤坏死因子-α(TNF-α),白细胞介素(IL-6和IL-10)的浓度( ELISA),通过流式细胞术测定肾细胞凋亡率。观察三组小鼠的4天和7天存活率[5]。
参考文献

[1]. Garcia-Calvo M, et al.nhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 1998 Dec 4;273(49):32608-13.

[2]. Jinglin Wang, et al. A polysaccharide from Lentinus edodes inhibits human colon cancer cell proliferation and suppresses tumor growth in athymic nude mice. Oncotarget. 2017 Jan 3; 8(1): 610-623.

[3]. Junping Zhang, et al. Hypericin-mediated photodynamic therapy induces apoptosis of myoloma SP2/0 cells depended on caspase activity in vitro. Cancer Cell Int. 2015; 15: 58

[4]. Long-gang He, et al. Sinomenine induces apoptosis in RAW 264.7 cell-derived osteoclasts in vitro via caspase-3 activation. Acta Pharmacol Sin. 2014 Feb; 35(2): 203-210.

[5]. Liu LX, et al. The effect of caspase-3 inhibitor on the concentrations of serum inflammatory cytokines in sepsis related acute kidney injury induced by peritoneal cavity infection in mice. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 Dec;22(12):736-9.

密度 1.374g/cm3
沸点 1021.1ºC at 760mmHg
分子式 C20H30N4O11
分子量 502.47200
闪点 571.3ºC
精确质量 502.19100
PSA 245.37000
蒸汽压 0mmHg at 25°C
折射率 1.535
储存条件 -20°C

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name: N-Acetyl-Asp-Glu-Val-Asp-al
REACH No.: A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No.: 169332-60-9
Relevant identified uses of the substance or mixture and uses advised against
Identified uses: Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Synonyms: Ac-DEVD-CHO
Formula: C20H30N4O11
Molecular Weight: 502,47 g/mol
CAS-No.: 169332-60-9
No components need to be disclosed according to the applicable regulations.

SECTION 4: First aid measures
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapours, mist or gas.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: -20 °C
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) AppearanceForm: powder
b) Odourno data available
c) Odour Thresholdno data available
d) pHno data available
e) Melting point/freezingno data available
point
f) Initial boiling point and no data available
boiling range
g) Flash pointno data available
h) Evapouration rateno data available
i) Flammability (solid, gas) no data available
j) Upper/lowerno data available
flammability or
explosive limits
k) Vapour pressureno data available
l) Vapour densityno data available
m) Relative densityno data available
n) Water solubilityno data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignitionno data available
temperature
q) Decompositionno data available
temperature
r) Viscosityno data available
s) Explosive propertiesno data available
t) Oxidizing propertiesno data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong acids, Strong bases
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: -IMDG: -IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA:Not dangerous goods
Transport hazard class(es)
ADR/RID: -IMDG: -IATA: -
Packaging group
ADR/RID: -IMDG: -IATA: -
Environmental hazards
ADR/RID: noIMDG Marine pollutant: noIATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A
个人防护装备 Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
危险品运输编码 NONH for all modes of transport
WGK德国 3